CASK
protein-codingcalcium/calmodulin dependent serine protein kinase, the group of PDZ domain containing|Membrane associated guanylate kinases
Gene summary
This gene encodes a calcium/calmodulin-dependent serine protein kinase. The encoded protein is a MAGUK (membrane-associated guanylate kinase) protein family member. These proteins are scaffold proteins and the encoded protein is located at synapses in the brain. Mutations in this gene are associated with FG syndrome 4, intellectual disability and microcephaly with pontine and cerebellar hypoplasia, and a form of X-linked intellectual disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
- TNRC8
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~408.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010318
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0100062
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010318
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010417
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010417
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0020119
Submitter: ClinGen
*CASK*, which encodes a synaptic scaffolding protein, was first reported in relation to X-linked syndromic intellectual disability in 2008 (Najm et al., PMID: 19165920). Sixteen variants (nonsense, splice, frameshift, start loss, missense) that have been reported in 18 probands in four publications (PMIDs: 19165920, 21735175, 21954287, 25886057) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. Some cases could not be scored because the deletions were larger than 10 kb (see Moog et al., 2011, PMID: 21954287, and Moog et al., 2015, PMID: 25886057). This gene-disease relationship is also supported by mouse models that recapitulate the phenotype in humans. In summary, there is definitive evidence supporting the relationship between *CASK* and X-linked syndromic intellectual disability. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on July 9, 2019 (SOP Version 6).
Inheritance Pattern: XL
Disease ID:MONDO:0010417
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010318
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010417
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CASK variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001367721.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 17 | 161 | 19 | 199 |
| missense | 7 | 35 | 353 | 37 | 9 | 441 |
| nonsense | 43 | 13 | 8 | 64 | ||
| start loss | 2 | 1 | 3 | |||
| frameshift | 37 | 28 | 2 | 67 | ||
| splice donor/acceptor (+/-2bp) | 20 | 28 | 35 | 1 | 84 | |
| Total | 110 | 105 | 416 | 198 | 29 | 858 |
Highest pathogenic variant AF is 0.0000018603024
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001354650.1 | 27 | MANE Select | |
| Ensembl | ENSP00000367405.1 | 27 | MANE Select | |
| RefSeq | NP_001119526.1 | 26 | Standard | |
| RefSeq | NP_001119527.1 | 25 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Parkin-Ubiquitin Proteasomal System pathway
- Splicing factor NOVA regulated synaptic proteins
- Extracellular matrix organization
- Neuronal System
- Dopamine Neurotransmitter Release Cycle
Biological Process
- negative regulation of cell-matrix adhesion
- protein phosphorylation
- cell adhesion
- neurotransmitter secretion
- negative regulation of keratinocyte proliferation
Molecular Function
- guanylate kinase activity
- protein serine/threonine kinase activity
- protein binding
- calmodulin binding
- ATP binding
Cellular Component
- basement membrane
- nuclear lamina
- nucleolus
- cytoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000378166
- Coding exons
- 27
- Length
- 408530
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.25 | 133 | 360 | 0.370 | 0.0000274 | 6089 |
| Missense (PolyPhen) | 36 | 137.85 | 0.26115 | 2260 | ||
| Synonymous | 0.0828 | 130 | 131 | 0.991 | 0.0000108 | 1710 |
| Loss of Function | 5.93 | 0 | 41.0 | 0.00 | 0.00000315 | 669 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Multidomain scaffolding protein with a role in synaptic transmembrane protein anchoring and ion channel trafficking. Contributes to neural development and regulation of gene expression via interaction with the transcription factor TBR1. Binds to cell-surface proteins, including amyloid precursor protein, neurexins and syndecans. May mediate a link between the extracellular matrix and the actin cytoskeleton via its interaction with syndecan and with the actin/spectrin-binding protein 4.1.;
- Disease
- DISEASE: Mental retardation and microcephaly with pontine and cerebellar hypoplasia (MICPCH) [MIM:300749]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Affected individuals can manifest a severe phenotype consisting of severe intellectual deficit, congenital or postnatal microcephaly, disproportionate brainstem and cerebellar hypoplasia. A milder phenotype consists of mental retardation alone or associated with nystagmus. {ECO:0000269|PubMed:19165920, ECO:0000269|PubMed:19377476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: FG syndrome 4 (FGS4) [MIM:300422]: FG syndrome (FGS) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation. {ECO:0000269|PubMed:19200522}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.277
Intolerance Scores
- LoFtool
- 0.0574
- RVIS EVS
- -0.71
- RVIS percentile EVS
- 14.4
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.801
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |